Skip to main content

Table 2 Future Targets

From: Novel targets for potential therapeutic use in Diabetes mellitus

Compound

Class

Mode of action

Potential role in diabetes

References

11β Hydroxysteroid dehydrogenase

Glucocorticoids

High levels cause glucose intolerance

By inhibiting 11β-HSD Decrease in blood glucose levels, improved insulin sensitivity

[55]

ACRP-30

Hormone

Low levels cause insulin sensitivity

Increase in Acrp30 will increase the insulin sensitivity and decrease in blood glucose levels

[56,57,58]

FETUIN-A

Glycoprotein

Involved in the inflammation of the β-cells

Low levels of Fetuin-A will increase the insulin sensitivity

[59]

VISFATIN

Protein

Attaches to the insulin receptor

Insulin-mimetic action

[60]

METRNL

Adipokine

Cause up regulation of the PPARγ pathway

Increase in the insulin sensitivity

[61]

[62, 63]

PEDF (Pigment epithelium-derived factor)

Glycoprotein

Increase kinase-mediated Serine/Threonine phosphorylation cascade of IRS which causes insulin resistance

Decreasing level of PEDF increases the insulin sensitivity

[64]

VASPIN (SERPIN A12)

Serum glycoprotein

Vaspin performs its action by inhibiting the KLK7

Due to inhibition of KLK7, insulin signalling is improved and also the half-life of insulin is increased that helps in decreasing the blood glucose levels

[65, 66]

GPER (G protein-coupled estrogen receptor)

Glycoprotein

Regulation of glucose homeostasis by binding to both Gi/o and Gs proteins

Increase insulin secretion

[67,68,69]

GENE THERAPY

Gene

Act by correcting or repairing the defective genes

Suppression of auto reactive T cells to stop islet cells destruction

[70, 71]